Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Bayer : launches transparency register for scientific collaborations with external partners

09/16/2021 | 05:02am EDT
Thursday - September 16, 2021
Launch of Bayer Science Collaboration Explorer:
Bayer launches transparency register for scientific collaborations with external partners
Open access database makes new contract-based scientific collaborations with universities, public research institutions and individuals publicly available in Germany

Leverkusen, September 16, 2021 - Bayer AG is the first company in the future DAX-40-index to introduce a transparency register. The Bayer Science Collaboration Explorer is aimed at improving long-term public confidence in science and research. The database (bayer.com/bsce) provides access to new contract-based scientific collaborations with universities, public research institutions and individuals in Germany.

'Solving humanity's major challenges requires trusted scientific innovations. For that, we need transparency,' says Bayer AG CEO Werner Baumann. 'Today we are presenting the Bayer Science Collaboration Explorer, a leading initiative setting standards for corporate transparency and community engagement.'

Dr. Monika Lessl, Head of Corporate R&D and Social Innovation at Bayer, added: 'With the Bayer Science Collaboration Explorer, Bayer and our external partners want to create more transparency regarding our scientific collaborations. We see the register as an important element towards promoting dialogue between society, business, and research on the topic of new scientific discoveries.' The transparency register will initially launch in Germany before being introduced in further countries.

Specifically, the following core details will be published for each contract: Name and country of the institution/person, collaboration type (e.g., research contract), subject of collaboration (e.g., oncology, digital farming), funding committed, effective date, participating Bayer division.

Announcement during Bayer Transparency Day - Inside Science

At 2:00 p.m. on September 16, 2021, Werner Baumann, CEO of Bayer AG, will introduce the Bayer Science Collaboration Explorer during Bayer's virtual 'Transparency Day - Inside Science' event. Following its publication, experts from science, business, media, and civil society will discuss the following theme: 'Collaborations between companies and research institutions: Transparency as a key to societal trust?' A recording will be made available on the event website (bayer-transparency-day.com) after the event.

You can find out more about the Bayer Science Collaboration Explorer here (bayer.com/bsce).

About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.


Bayer AG published this content on 16 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 September 2021 09:01:01 UTC.

© Publicnow 2021
All news about BAYER AG
10/21PRESS RELEASE : Pfizer and BioNTech Announce Phase -3-
10/20BAYER : Mexico's agriculture minister say Mexico will not limit GMO corn imports from U.S.
10/20BAYER AG : Barclays reaffirms its Neutral rating
10/20BAYER AG : UBS keeps its Buy rating
10/19BAYER : Sticks To 2021 Guidance Amid Production Halt, Changing Planting Habits
10/19BAYER : farmers pre-buying crop inputs as supply-chain snarls continue
10/18BAYER AG : Receives a Buy rating from JP Morgan
10/18BAYER : Belmora Seeks SCOTUS Review For The Second Time In Its Cross-Border Trademark Batt..
10/15CureVac Shares Down 12%
10/15BAYER AG : Gets a Buy rating from DZ Bank
More news
Analyst Recommendations on BAYER AG
More recommendations
Sales 2021 42 403 M 49 331 M 49 331 M
Net income 2021 864 M 1 005 M 1 005 M
Net Debt 2021 39 365 M 45 797 M 45 797 M
P/E ratio 2021 25,7x
Yield 2021 4,23%
Capitalization 47 343 M 55 127 M 55 078 M
EV / Sales 2021 2,04x
EV / Sales 2022 1,94x
Nbr of Employees 99 439
Free-Float 100,0%
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 48,19 €
Average target price 61,36 €
Spread / Average Target 27,3%
EPS Revisions
Managers and Directors
Werner Baumann Chairman-Management Board & CEO
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BAYER AG0.07%55 127
JOHNSON & JOHNSON3.83%430 148
ROCHE HOLDING AG15.79%339 425
PFIZER, INC.16.27%240 303
NOVO NORDISK A/S56.55%239 079